Indian Lenalidomide Exporters: Complete Supplier Ranking with Market Share — 557 Manufacturers (2026) — TransData Nexus

Q: Who is the largest lenalidomide buyer importing from India?

SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES) is the largest lenalidomide importer from India with a 21.6% market share and import value of $190.9M.

Q: How many lenalidomide buyers import from India?

There are 557 active lenalidomide buyers importing from India, with a combined import market of $883.1M across 2,724 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top lenalidomide buyers from India?

The top 5 lenalidomide buyers — SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIESINC., AUROBINDO PHARMA USA., INC,, SUN PHARMACEUTICAL INDUSTRIES INC, CIPLA USA INC UPS SUPPLY CHAIN SOL — together control 69.1% of total lenalidomide import value from India.

Suresh Sormare

Lenalidomide

India Pharmaceutical Trade Intelligence

$883.1M237 Suppliers122 CountriesHS 30049049

ExportsIndia → UNITED STATES96.7%India → JAPAN0.6%

ImportsUNITED STATES → India$1.6M SWITZERLAND → India$1.3M

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: SUN PHARMACEUTICAL

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $853.7M through 79 shipments. This represents a market share of 96.7% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• SUN PHARMACEUTICAL INDUSTRIES,INC. - $190.9M (22.4% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIESINC. - $126.6M (14.8% of country's total business)

• AUROBINDO PHARMA USA., INC, - $114.8M (13.4% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIES INC - $100.8M (11.8% of country's total business)

• CIPLA USA INC UPS SUPPLY CHAIN SOL - $77.0M (9.0% of country's total business)

• Rest of United States's importers - $243.5M (28.5% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $10.8M, indicating premium pricing strategy compared to the market average of $324.2K.

United States is a key market for Lenalidomide imports, representing 96.7% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Lenalidomide buyer market intelligence

1Buyer Segment Analysis

The 557 buyers of Lenalidomide from India can be categorized into several segments:

1. Pharmaceutical Companies: Entities like Sun Pharmaceutical Industries Inc. and Aurobindo Pharma USA Inc. are major buyers, accounting for significant import values. These companies typically procure large quantities to support their manufacturing and distribution operations, ensuring a steady supply chain for their products.

2. Distributors: Companies such as Yusen Logistics Benelux Belgium and Brocacef NL Hub in the Netherlands function as intermediaries, purchasing Lenalidomide in bulk and supplying it to various healthcare providers. Their buying behavior is characterized by regular, large-volume orders to meet the demands of their client base.

3. Re-exporters: Some buyers may act as re-exporters, importing Lenalidomide from India and then exporting it to other countries. This segment's order patterns are influenced by global market demands and regulatory environments in target markets.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Lenalidomide buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Lenalidomide are as follows:

1. United States:

Regulatory Authority: Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Lenalidomide is FDA-approved and complies with all labeling and safety requirements. The FDA's Safe Importation Action Plan outlines pathways for importing certain prescription drugs, including those from Canada.

Estimated Timeline for Registration: Varies; the FDA evaluates importation proposals on a case-by-case basis.

Import Tariff/Duty for HS 30049049: Generally, pharmaceutical products under this HS code are subject to minimal or zero tariffs, but importers should verify current rates with U.S. Customs and Border Protection.

2. Japan:

Regulatory Authority: Pharmaceuticals and Medical Devices Agency (PMDA).

Demand Drivers & Market Opportunity

TransData Nexus Lenalidomide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Lenalidomide in importing countries is driven by several factors:

1. Disease Prevalence: Lenalidomide is primarily used to treat multiple myeloma and certain types of anemia. The prevalence of these conditions influences demand. For instance, the American Cancer Society estimated that in 2025, approximately 35,000 new cases of multiple myeloma would be diagnosed in the United States, indicating a substantial patient population requiring treatment.

2. Government Healthcare Programs and Universal Health Coverage Expansion: Countries expanding their healthcare coverage increase access to essential medicines. For example, Canada's universal healthcare system ensures that approved medications like Lenalidomide are accessible to patients, thereby driving demand.

3. WHO Essential Medicines List Procurement and Tender-Based Purchasing: Lenalidomide's inclusion in the World Health Organization's List of Essential Medicines underscores its importance. Many countries rely on this list to guide procurement decisions, often through tender-based purchasing systems to ensure cost-effectiveness and supply security.

With 557 buyers across 122 countries, the global reach of Lenalidomide underscores its critical role in oncology treatment worldwide.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Lenalidomide Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest lenalidomide buyer importing from India?

Based on import volume and value, SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES) leads with $190.9M in imports and a 21.6% market share — the highest of any single lenalidomide importer. SUN PHARMACEUTICAL INDUSTRIESINC. (UNITED STATES) and AUROBINDO PHARMA USA., INC, (UNITED STATES) are the next largest buyers.

QHow many companies buy lenalidomide from India?

There are 557 active lenalidomide buyers importing from India, with a combined market of $883.1M across 2,724 shipments to 122 countries. The top 5 buyers hold 69.1% of total import value, while the remaining 552 buyers handle the other 30.9%.

QWhich countries import the most lenalidomide from India?

The top importing countries for lenalidomide from India are United States (96.7%), Japan (0.6%), Netherlands (0.4%), Canada (0.4%), Colombia (0.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of lenalidomide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for lenalidomide from India?

The average import transaction value for lenalidomide from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Lenalidomide buyer market intelligence

1Buyer Segment Analysis

The 557 buyers of Lenalidomide from India can be categorized into several segments:

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Lenalidomide buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Lenalidomide are as follows:

1. United States:

Regulatory Authority: Food and Drug Administration (FDA).

Estimated Timeline for Registration: Varies; the FDA evaluates importation proposals on a case-by-case basis.

2. Japan:

Regulatory Authority: Pharmaceuticals and Medical Devices Agency (PMDA).

Demand Drivers & Market Opportunity

TransData Nexus Lenalidomide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Lenalidomide in importing countries is driven by several factors:

With 557 buyers across 122 countries, the global reach of Lenalidomide underscores its critical role in oncology treatment worldwide.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Lenalidomide

Lenalidomide

Who Buys Lenalidomide from India — 557 Importers Behind a $883.1M Market

Top Lenalidomide Importers — Ranked by Import Value

Top Lenalidomide Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Lenalidomide — and from which countries?

Lenalidomide — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Lenalidomide Buyers & Importers

QWho is the largest lenalidomide buyer importing from India?

QHow many companies buy lenalidomide from India?

QWhich countries import the most lenalidomide from India?

QWhat is the average import order value for lenalidomide from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Japan

3Netherlands

4Canada

5Colombia

Analysis Methodology